What is Biote Corp.'s other commercial liabilities?

Biote Corp. (BTMD) reported other commercial liabilities of $10.28M in Q1 2026.

How has Biote Corp.'s other commercial liabilities changed year-over-year?

Biote Corp.'s other commercial liabilities increased by 0.5% year-over-year, from $10.23M to $10.28M.

Biote Corp. BTMD Other Commercial Liabilities

Other Commercial Liabilities at other companies

TargetTGT

——

Walmart WMT

——

Lifecore Biomedical, Inc.LFCR

——

BioLife SolutionsBLFS

——

NAG

Niagen Bioscience, Inc. Common StockNAGE

——

Lifevantage CorporationLFVN

——

Other financials

Income statement

See full

Revenue$44.9M-8.3%

Gross profit$31.0M-14.9%

Operating income$3.2M-67.3%

Net income$2.3M-83.4%

EPS (diluted)$0.06-83.8%

Balance sheet

See full

Cash & equivalents$5.3M-87.2%

Total debt$103.4M-5.5%

Total equity-$56.1M+37.7%

Total assets$89.0M-27.8%

Cash flow

See full

Operating cash flow$3.9M-39.7%

CapEx$362.0K-77.8%

Free cash flow$3.5M-26.8%

Valuation

See full

Market cap$57.33M-51.2%

Enterprise value$155.43M-26.5%

P/E3.7×-0.1×

P/S0.3×-0.3×

Profitability

See full

Gross margin70.1%-1.2pp

Operating margin15.4%-0.1pp

Net margin8.3%-2.3pp

FCF margin15.3%-3.2pp

Returns & leverage

See full

Return on equity-21.4%—

Debt / equity9.1×—

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biote Corp.'s other commercial liabilities?: Biote Corp. (BTMD) reported other commercial liabilities of $10.28M in Q1 2026.
How has Biote Corp.'s other commercial liabilities changed year-over-year?: Biote Corp.'s other commercial liabilities increased by 0.5% year-over-year, from $10.23M to $10.28M.